Best Life Sciences Companies in Saxony, Germany
The 55 best Life Sciences companies in Saxony, Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Anvajo.
Our analysis of 50 Life Sciences companies
$3.3b in tracked funding; 51% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2024.
Ranked: Best Life Sciences companies in Saxony
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | AI-Driven Therapeutics Developer of AI-powered solutions for protein design and drug discovery | — | — | — | Paul Eisenhuth Co-Founder | — | — | 1 award |
| 2 | Amedtec Developer of an ECG screening and diagnosis device | — | — | 27 | Herr Claus Schrodter CEO | — | — | — |
| 3 | BellaSeno Developer of breast implants | — | — | 17 | Dietmar Hutmacher Co-Founder | WordPressMySQLPHP+9 | 75 patents Patents concentrated in health & consumer products | 1 partnership |
| 4 | Biophysical Tools Provider of microfluidics instrument system | — | — | — | Katja Prasol Co-Founder & CEO | — | — | — |
| 5 | Biotype Developer of in vitro diagnostic kits for multiplex PCR | — | — | — | Wilhelm Zorgiebel Co-Founder & CEO | WebflowPlausibleBunny+8 | 36 patents Multiplexed nucleic acid detection and cancer biomarker diagnostics using tailored probe competition. | 1 launch |
| 6 | DKMS Life Science Lab Provider of Immunogenetic genotyping services | — | — | — | Alexander Schmidt CEO | Kontent.aiSentrySalesforce+12 | — | — |
| 7 | EPITOPIC Provider of cell therapy and antibody services | — | — | — | Michael Szardenings CEO | — | — | — |
| 8 | FAN Analyzers for detection of H.pyroli infections | — | — | — | Martin Schaich CEO | WordPress Site EditorWordPressMySQL+9 | — | — |
Top 12 Life Sciences companies in Saxony
#1
Seed · Dresden, Saxony · founded 2022$12.5Mraised▾
Provider of gene-editing platform for targeted therapeutics. The company pioneers a novel recombinase platform that unlocks the reprogramming of recombinases, a highly versatile class of enzymes to develop therapeutics to transform the treatment of severe diseases.
- Mar 2023Seed$12.5M
#2
Acquired · Leipzig, Saxony · founded 2004 · 100 employees$2.3Mraised▾
c-LEcta specializes in the discovery and production of enzymes & microbial strains for industrial applications in sectors such as pharma and food. Its product portfolio includes a number of enzymes such as Nucleanase, Denarase, Acrylaway HighT etc. The company has 8 products (API intermediate, Ingredient, Prebiotic etc.) in its pipeline. Also c-LEcta offers customized enzyme optimization services to the clients.
- Jan 2023Grant (prize money)$279.5K
- Sep 2019Grant (prize money)$134.2K
- Jan 2019Grant (prize money)$459.5K
- Aug 2018Series B—
#3
Series A · Dresden, Saxony · founded 2016 · 66 employees$17.3Mraised▾
Provider of point-of-care solutions for laboratory diagnostics. The company offers a free desktop application called the anvajo datalab for scientists to access measurement data acquired with the fluidlab R-300.
- Oct 2022Series A$17.3M
- Jun 2016Seed—
#4
Seed · Dresden, Saxony · founded 2016 · 12 employees$193Kraised▾
denovoMATRIX develops modular biomimetic matrices. Their products include screenMATRIX (which include a cell culture plate containing a different microenvironment) and myMATRIX (combination of sulfated polysaccharides and biomimetic peptides). These products have applications in the field of stem cell research, drug development, tissue models, and cell-based therapies.
- Jun 2023Seed—
- Jul 2021Grant (prize money)$193K
- Dec 2018Seed—
#5
Funding Raised · Dresden, Saxony · founded 2012 · 24 employees$1.7Mraised▾
Lipotype is an expert in lipidomics, a lipid-based analysis of organelles, microorganisms, cultured cells to tissues and organs by using lipo type shotgun technology. The technology involves mass spectrometry-based analysis and bioinformatics tools to quantify all the lipid species present in the body fluid. Most diseases have been known to show deranged lipid profile and absolute quantification would aid clinical diagnostics. Similarly, the technology also finds application in food, cosmetic, and dermatology industry.
- Mar 2020Grant (prize money)$838.6K
- Jan 2020Grant (prize money)$820.4K
- Mar 2017Grant (prize money)$75.8K
#6
Series A · Leipzig, Saxony · founded 2009 · 3 employees$4.5Mraised▾
Developer of treatments for multi-drug-resistant gram-negative infections. The company is focused on developing drugs for severe hospital-acquired bacterial infections predominantly caused by (multi)drug-resistant Gram-negative bacteria. It is developing its lead compounds based on the sequences of antimicrobial peptides from insects. It claims that proline-rich antimicrobial peptides from the apidaecin and oncocin families selectively kill Gram-negative bacteria.
- Oct 2012Grant (prize money)$2.2M
- Oct 2012Grant (prize money)$2.3M
- 2011Series A—
#7
Deadpooled · Radebeul, Saxony · founded 2010$6.8Mraised▾
BioCrea is a German drug development company focusing on neurological and psychotic disorders (ALS, Huntington's, Schizophrenia, etc.). They have proprietary compound library & patient-derived IPSC (induced pluripotent stem cell) screening platform. It has one drug candidate, PDE10 inhibitor, in the preclinical stage, to treat schizophrenia and Huntington’s disease indications. It has partnerships with biotechnology and pharmaceutical companies (such as Boehringer Ingelheim, Pfizer, GlaxoSmithKline). In 2013, Imepitoin, discovered by BioCrea, developed and launched by Boehringer Ingelheim, received European approval for canine epilepsy.
- Nov 2010Series A$6.8M
#8
Funding Raised · Dresden, Saxony · founded 2010 · 11 employees$43.3Kraised▾
AXO Dresden produces both single X-ray optics and complex X-ray optical systems to generate high intensity collimated or focussed monochromatic X-ray beams, special customized depositions and applications in X-ray reflectometry and diffraction. A wide assortment of flat and curved X-ray optics are available that can be used with the common types of X-ray sources with respect to wavelength, construction and focus geometry. AXO DRESDEN develops and applies various high precision deposition techniques for the production of nanometer single and multilayers showing sub-nanometer precision. The company works in close collaboration with the Fraunhofer IWS, further Fraunhofer Institutes, the University of Technology Dresden as well as with other national and international research institutes. AXO DRESDEN (Applied X-ray Optics and High Precision Deposition) was founded as a Spin-off from the Fraunhofer Institute Material and Beam Technology Dresden (IWS) with a participating share of the Fraunhofer Society.
- Dec 2021Grant (prize money)$43.3K
#9
Seed · Radebeul, Saxony · founded 2009 · 4 employees$1.2Mraised▾
Provider of siRNA reagents, miRNA mimics, and immunomodulators for research application. The technologies are the basis of two business lines of Riboxx Life Sciences which is dedicated to the development of RNA reagents for life sciences and Riboxx Pharma which is dedicated to the development and industrial manufacturing of immunomodulators; for therapeutic vaccines (against cancer) and prophylactic vaccines (against infections).
- Jan 2015Seed$1.2M
- 2010Seed—
- 2010Grant (prize money)$4.7M
#10
Funding Raised · Leipzig, Saxony · founded 2012$559.5Kraised▾
Provider of computational tools for the analysis of genomic sequencing data. EcSeq provides bioinformatics training covering the analyses of different high-throughput sequencing experiments. They also offer Knowledge-Driven NGS Solutions. They have established a wide network of scientists, covering all research fields relevant to NGS. Together with a project-specific expert panel, they can analyze NGS data in a scientifically proven manner to provide meaningful, knowledge-driven results. Their customers include large research organizations such as the Max-Planck Institute and the Helmholtz Centre, universities, hospitals, as well as large biotechnology and pharmaceutical companies.
- Sep 2017Grant (prize money)$295.6K
- Jan 2017Grant (prize money)$263.9K
#11
Seed · Leipzig, Saxony · founded 2007 · 8 employees$1.4Mraised▾
Scienova engages in manufacturing lab sample preparation disposables. Along with this the company also manufactures dialysis systems, sample dialysis, dialyzer, laboratory dialysis, sample preparation consumable, dialysis tubings, dialysis accessories, labeling solutions, protein column, and micro dialyzer for Desalting of proteins and other macromolecules, Rebuffering of proteins and other macromolecules, Renaturation / Denaturation of proteins Binding studies (e.g. hormon or drug protein binding studies), and Removal of disturbing substances like urea from macromolecular substances.
- Dec 2008Seed$1.4M
#12
Series A · Leipzig, Saxony · founded 1994 · 2 employees$1.2Mraised▾
Provider of bio-analytical products and services designed to address issues in drug discovery. The company's ADMET kits include absorption, distribution, metabolism, and excretion toxicity tests used in pharmacokinetics, enabling customers to obtain rapid, accurate and reproducible pharmacokinetic data and side-effect predictions about candidate drugs or other test substances.
- May 2009Series A—
- Mar 2007Series A$1.2M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Germany
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,297 Germany-affiliated papers.
- Heidelberg University85
- German Cancer Research Center49
- Ludwig-Maximilians-Universität München48
- Technical University of Munich43
- Karlsruhe Institute of Technology33
- Gene3→29
- Mutant3→19
- Transcription (linguistics)3→16
- Messenger RNA1→14
- Immune system1→12
- Gene3→20
- Agriculture2→12
- Extracellular1→11
- Immune system1→11
- Transcriptome1→9
- Antibiotic resistance2→9
- Gene1→7
- Agriculture4→9
- Antimicrobial1→4
- Microbiome1→4
Where biotechnology is researched across Germany
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in Germany
Germany biotechnology patent filing is cooling — 53,233 filings from 8,000 assignees (2016–2025), led by Immatics Biotechnologies, BASF Plant Science, BASF SE; annual filings 4819→4267.
- Immatics Biotechnologies4872
- BASF Plant Science3982
- BASF SE3543
- Boehringer Ingelheim INT3438
- Merck Patent3133
- MAX Planck Gesellschaft1799
- Evonik Degussa1680
- Amgen RES Munich1665
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.